$PLRZ
Polyrizon Ltd.
Nasdaq · Healthcare · Surgical & Medical Instruments & Apparatus · Ra'Anana
PLRZ chart
What traders are saying about $PLRZ
Latest postsPolyrizon Ltd. news
- Polyrizon completes enrollment of 120 patients in U.S. study for NASARIX allergy blocker
Pluang ·
- Across five U.S. sites, Polyrizon (PLRZ) completes enrollment in its nasal allergy study.
Stock Titan ·
- Polyrizon completes enrollment in NASARIX allergy study By Investing.com
Investing.com Nigeria ·
- Polyrizon completes enrollment of 120 patients in U.S. Nasarix study
StreetInsider ·
- Polyrizon Announces Completion of Enrollment and Randomization in U.S. Clinical Study of NASARIX for Allergic Rhinitis
Quiver Quantitative ·
- Polyrizon Announces Successful Completion Enrollment of all 120 Patients in U.S. Clinical Study of NASARIX Allergy Blocker
Yahoo Finance ·
- A study of an experimental nasal allergy barrier has enrolled all 120 participants
Stock Titan ·
- Polyrizon Ltd. Estimates – NASDAQ:PLRZ
TradingView ·
- Polyrizon Files for U.S. Patent Application to Expand IP Moat Around Intranasal Drug-Delivery Platform
Yahoo Finance ·
- Polyrizon Enrolls First Patient in U.S. Clinical Study of NASARIX (PL-14) Allergy Blocker
Yahoo Finance ·
- Polyrizon Ltd. Announces Closing of $4.0 Million Registered Direct Offering and Private Placement
Yahoo Finance ·
- Polyrizon Ltd. Announces $4.0 Million Registered Direct Offering and Private Placement
Yahoo Finance ·
Polyrizon Ltd. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | -$3.3M | -$1.5M | -$600,000 | -$779,000 |
| Diluted EPS | $4.90 | $805.20 | $494.40 | $0.60 |
| Total assets (year end) | $21.4M | $5.5M | $559,000 | – |
| Cash and equivalents (year end) | $1.3M | $2.6M | $4,000 | – |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
About Polyrizon Ltd.
- Ticker
- PLRZ (Nasdaq)
- Industry
- Surgical & Medical Instruments & Apparatus
- Headquarters
- Ra'Anana
- Incorporated in
- Israel
- Fiscal year end
- December 31
- SEC CIK
- 1893645
Frequently asked questions
What exchange is Polyrizon Ltd. listed on?
Polyrizon Ltd. trades on the Nasdaq under the ticker symbol PLRZ.
What industry is Polyrizon Ltd. in?
Polyrizon Ltd. is classified by the SEC under "Surgical & Medical Instruments & Apparatus", part of the Healthcare sector on StockTweeting.
Where is Polyrizon Ltd. headquartered?
Polyrizon Ltd.'s business address on file with the SEC is in Ra'Anana.
When does Polyrizon Ltd.'s fiscal year end?
Polyrizon Ltd.'s fiscal year ends on December 31.